HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mild hemolytic anemia, progressive neuromotor retardation and fatal outcome: a disorder of glycolysis, triose- phosphate isomerase deficiency.

Abstract
A two-month-old male infant presented with jaundice, pallor, and hepatomegaly. The first child of non-consanguineous parents had also suffered from hemolytic anemia and neuromotor retardation and died at the age of 21 months. The patient required phototherapy and transfusion in the newborn period but hemolysis was mild thereafter. The patient had neuromotor retardation, and at the age of 14 months, ventilatory support was necessary, and the patient lived until 17 months. Triose-phosphate isomerase (TPI) deficiency, which is a rare autosomal recessive multisystem disorder of glycolysis, was detected. There was homozygous missense mutation in the TPI1 gene (p.Glu105Asp). This is the most common mutation with a severe phenotype that requires ventilator support in the second year of life. In patients with hemolysis and neuromotor retardation, TPI deficiency must be considered. There is no specific treatment, but detection of the index case may provide the opportunity for genetic counseling and prenatal diagnosis.
AuthorsNazan Sarper, Emine Zengin, Cornelis Jakobs, Gajja S Salomons, Mirjam Mc Wamelink, Markus Ralser, Koray Kurt, Bülent Kara
JournalThe Turkish journal of pediatrics (Turk J Pediatr) 2013 Mar-Apr Vol. 55 Issue 2 Pg. 198-202 ISSN: 0041-4301 [Print] Turkey
PMID24192681 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Triose-Phosphate Isomerase
Topics
  • Anemia, Hemolytic, Congenital Nonspherocytic (diagnosis, genetics, therapy)
  • Fatal Outcome
  • Genetic Counseling
  • Glycolysis
  • Humans
  • Infant
  • Male
  • Metabolism, Inborn Errors
  • Motor Skills
  • Mutation, Missense
  • Prenatal Diagnosis
  • Respiration, Artificial
  • Triose-Phosphate Isomerase (deficiency)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: